Originally published by our sister publication Anesthesiology News
By Michael Vlessides
LAS VEGAS—A multimodal analgesic regimen consisting of zopiclone, gabapentin and/or celecoxib did not confer any benefits over a standard opioid-based approach in patients following hip arthroscopy, according to the results of a new study.
The investigation, which was presented at the 2023 annual meeting of the American Academy of Orthopaedic Surgeons, found no differences between groups in terms of pain